Clinic
VXL Medical Care PC
VXL Medical Care PC was paid $2.22M by Medicaid between Jan 2018 and Nov 2024, across 57 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoVXL MEDICAL CARE PC
ELMHURST, NY 11373
ELMHURST, NY 11373
33aNPI1528192515assigned 03/14/2007
33bProvider typeHealth Service Clinic/Center
28Total paid$2.22M
24GClaims53,151
24DCodes billed57
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Health Service Clinic/Center providers in New York
Rank by total paid#17 of 54
Median peer was paid$410K
This provider vs. median5.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,413 | $74K | |
| 2019 | 3,938 | $127K | |
| 2020 | 8,246 | $315K | |
| 2021 | 10,285 | $466K | |
| 2022 | 9,772 | $423K | |
| 2023 | 11,447 | $492K | |
| 2024incomplete | 7,050 | $319K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 8,608 | 8,210 | $637K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 3,327 | 3,257 | $331K |
| 94060 | 13% | 7,676 | 7,565 | $298K | |
| 94729 | 7.9% | 4,301 | 4,291 | $175K | |
| 94726 | 7.6% | 4,322 | 4,313 | $169K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.3% | 802 | 802 | $118K |
| 94010 | 3.7% | 3,256 | 3,238 | $83K | |
| 94621 | 3.0% | 573 | 572 | $67K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.9% | 157 | 157 | $43K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.8% | 385 | 384 | $40K |
| 91320 | 1.4% | 344 | 344 | $31K | |
| 90674 | 1.3% | 1,000 | 1,000 | $30K |
45 more codes
| 92552 | 1.1% | 956 | $23K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,811 | $21K |
| 95117 | <1% | 1,574 | $17K | |
| 93000 | <1% | 1,247 | $17K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 162 | $17K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 367 | $15K |
| 90750 | <1% | 80 | $13K | |
| 90480 | <1% | 329 | $7K | |
| 0134A | <1% | 224 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 521 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 276 | $6K |
| 90694 | <1% | 132 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 415 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 24 | $4K |
| 90661 | <1% | 114 | $4K | |
| 94664 | <1% | 403 | $4K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 190 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 25 | $3K |
| 95921 | <1% | 42 | $3K | |
| 99243 | <1% | 30 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 89 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,941 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 142 | $2K |
| 96127 | <1% | 539 | $2K | |
| 0064A | <1% | 35 | $1K | |
| 99173 | <1% | 974 | $1K | |
| 90746 | <1% | 13 | $937.14 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 188 | $738.60 |
| 90686 | <1% | 30 | $505.05 | |
| 99406 | <1% | 29 | $348.75 | |
| 90653 | <1% | 28 | $243.20 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 25 | $232.34 |
| 3074F | <1% | 149 | $165.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 2,739 | $140.27 |
| 3078F | <1% | 111 | $140.00 | |
| 94761 | <1% | 92 | $126.15 | |
| G0008 | Administration of influenza virus vaccine | <1% | 34 | $125.62 |
| 92560 | <1% | 31 | $85.19 | |
| 1160F | <1% | 300 | $5.00 | |
| 91313 | <1% | 26 | $0.18 | |
| 91306 | <1% | 35 | $0.09 | |
| 3008F | <1% | 599 | $0.03 | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 49 | $0.01 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 180 | $0.00 |
| 3044F | 0% | 100 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJIVANI, ASLAM (PRESIDENT)